Work Here?
Adaptive Biotechnologies
Work Here?
Decodes immune cell receptors for diagnostics
Adaptive Biotechnologies
Work Here?
Decodes immune cell receptors for diagnostics
About Adaptive Biotechnologies
Industries
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Seattle, Washington
Founded
2009
Overview
Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue by partnering with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to advance healthcare by leveraging immune system data to develop better therapies and diagnostic tools.
Simplify's Take
What believers are saying
- Significant investments from equity firms indicate strong market confidence and growth potential.
- Participation in high-profile conferences suggests potential for new partnerships and collaborations.
- Winning Workplace of the Year Award highlights strong company culture and employee satisfaction.
What critics are saying
- Increased competition from startups like Adaptive with $20 million funding for AI models.
- New CFO may lead to strategic shifts impacting financial stability or direction.
- Focus on COVID-19 research may face reduced demand as pandemic attention wanes.
What makes Adaptive Biotechnologies unique
- Pioneers in immune-driven medicine, leveraging adaptive immune system for diagnostics and treatment.
- FDA-authorized clonoSEQ test for minimal residual disease in select blood cancers.
- Specializes in decoding genetic information of immune cell receptors for better diagnostics.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$531.9M
Above
Industry Average
Funded Over
8 Rounds
Benefits
Company Equity
Performance Bonus
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -2%2 year growth
↑ 0%Arizona State Retirement System invests $179,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT).
SEATTLE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.Adaptive Biotechnologies’ management is scheduled to present on Tuesday, January 14th at 5:15 p.m. Pacific Time / 8:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.About Adaptive BiotechnologiesAdaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease
Jacobs Levy Equity Management Inc. makes new $736,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT).
"We are inspired to see clonoSEQ MRD testing featured in a record-breaking number of studies at this year's ASH Annual Meeting," said Susan Bobulsky, chief commercial officer, MRD, Adaptive Biotechnologies.
Canada Pension Plan Investment Board makes new $98,000 Investment in Adaptive Biotechnologies Co. (NASDAQ:ADPT).
Adaptive Biotechnologies is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Adaptive Biotechnologies
Industries
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Seattle, Washington
Founded
2009
Adaptive Biotechnologies is Hiring for 8 Jobs on Simplify!
Find jobs on Simplify and start your career today